Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELL | P14151 | 2/20 | 0.42 |
| ▸ | SELP | P16109 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | CA3 | P07451 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | FUT4 | P22083 | 1/20 | 0.40 |
| ▸ | CA4 | P22748 | 1/20 | 0.40 |
| ▸ | CA6 | P23280 | 1/20 | 0.40 |
| ▸ | DPP4 | P27487 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10782332 | 0.85 | HSD17B10 (0.40) | SELLSELPALDH1A1HPGDHSD17B10 | |
| SCHEMBL27639352 | 0.85 | LDHA (0.49) | SELLSELPMCL1 | |
| SCHEMBL11121112 | 0.85 | HSD17B10 (0.43) | SELLSELPALDH1A1HPGDHSD17B10 | |
| SCHEMBL22629 | 0.85 | LDHA (0.49) | SELLSELPMCL1 | |
| SCHEMBL31324071 | 0.85 | HSD17B10 (0.43) | SELLSELPALDH1A1HPGDHSD17B10 | |
| SCHEMBL2135585 | 0.83 | SELL (0.45) | SELLSELPALDH1A1HPGDHSD17B10 | |
| Ethylgallate SCHEMBL29915692 | 0.83 | ESR1 (0.49) | TDP1KDM4ECA12CA1CA2 | |
| SCHEMBL7737317 | 0.83 | PTPN1 (0.40) | SELLSELPALDH1A1HPGDHSD17B10 | |
| Benzene SCHEMBL28179050 | 0.83 | LDHA (0.47) | THRBBCL2MCL1 | |
| SCHEMBL27803040 | 0.83 | LDHA (0.47) | MCL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3599633-B1 | POST ETCH RESIDUE CLEANING COMPOSITIONS AND METHODS OF USING THE SAME | VERSUM MAT US LLC (US) | 2023-12-06 | — | — | EP | claimed |
| EP-3589426-B1 | FURNITURE LUBRICANT COMPRISING A C10 TO C28 ALKANE AND A TRI-GLYCERIDE | IKEA SUPPLY AG (CH) | 2023-07-12 | — | — | EP | claimed |
| US-11380537-B2 | Method of manufacturing a semiconductor device and a cleaning composition for an adhesive layer | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2022-07-05 | — | — | US | claimed |
| EP-2115060-B1 | PRE-ACCELERATED RESIN COMPOSITION | AKZO NOBEL CHEMICALS INT BV (NL) | 2019-05-08 | — | — | EP | claimed |
| WO-2005077376-A1 | A STABLE PARENTAL FORMULATION OF LEVOMEPROMAZINE AND A METHOD FOR STABILIZING SAID FORMULATION | XANODYNE PHARMACEUTICALS, INC. (US) | 2005-08-25 | — | — | WO | claimed |
| US-20050176650-A1 | Stable parenteral formulation of levomepromazine and a method for stabilizing said formulation | XANODYNE PHARMACAL, INC. (US) | 2005-08-11 | — | — | US | claimed |
| WO-2026087658-A1 | RELEASE COAT FORMULATION, METHOD FOR PRODUCING PIGMENTS OR FOIL SECURITY FEATURES | GIESECKE+DEVRIENT CURRENCY TECHNOLOGY GMBH (DE) | 2026-04-30 | — | — | WO | disclosed |
| US-20250305010-A1 | LIPID COMPOSITIONS AND METHODS OF PRODUCING SAME | WILK TECHNOLOGIES INTERNATIONAL LTD. (IL) | 2025-10-02 | — | — | US | disclosed |
| US-20250255804-A1 | LIQUID INJECTABLE COMPOSITIONS OF LURBINECTEDIN | DR. REDDY'S LABORATORIES LIMITED (IN) | 2025-08-14 | — | — | US | disclosed |
| EP-4524141-A1 | SYNTHESIS OF ELLAGIC ACID FROM ETHYL GALLATE USING HYDROXIDES AND DEEP EUTECTIC SOLVENTS | Kemijski Institut (SI) | 2025-03-19 | — | — | EP | disclosed |
| EP-4522724-A1 | LIPID COMPOSITIONS AND METHODS OF PRODUCING SAME | Wilk Technologies International Ltd. (IL) | 2025-03-19 | — | — | EP | disclosed |
| US-11976241-B2 | Microencapsulated thermochromic materials and uses thereof | UNIVERSITY OF SOUTH FLORIDA (US) | 2024-05-07 | — | — | US | disclosed |
| WO-2024024502-A1 | POSITIVE-TYPE PHOTOSENSITIVE RESIN COMPOSITION | 日産化学株式会社 | 2024-02-01 | — | — | WO | disclosed |
| EP-0706094-A1 | An electro(stato)graphicmethod using reactive toners | AGFA-GEVAERT N.V. (BE) | 1996-04-10 | — | — | EP | disclosed |
| WO-1996001128-A2 | LOW-DOSE STEROID TABLETS CONTAINING GALLIC ACID ESTERS AS ANTIOXIDANT AGENT, PROCESS FOR THE MANUFACTURE OF SAID TABLETS, AND USES OF SAID TABLETS | SCHERING AKTIENGESELLSCHAFT (DE) | 1996-01-18 | — | — | WO | disclosed |
| EP-0671283-A1 | Thermal transfer imaging process | AGFA-GEVAERT N.V. (BE) | 1995-09-13 | — | — | EP | disclosed |
| EP-0641669-A1 | Ink jet recording method operating with a chemically reactive ink | AGFA-GEVAERT N.V. (BE) | 1995-03-08 | — | — | EP | disclosed |
| US-5316885-A | THERMAL TRANSFER PRINTING | KAO CORPORATION (JP) | 1994-05-31 | — | — | US | disclosed |
| EP-0472106-B1 | Pulverulent ink and printing methods | KAO CORP (JP) | 1994-02-16 | — | — | EP | disclosed |
| EP-0472106-A2 | Pulverulent ink and printing methods | KAO CORPORATION (JP) | 1992-02-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250255804-A1 | LIQUID INJECTABLE COMPOSITIONS OF LURBINECTEDIN | LPXN, RXFP1, LHCGR | SELL 1161/4885SELP 4453/4885ALDH1A1 2388/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.